151 related articles for article (PubMed ID: 7310816)
1. 5-Fluoro- and 5-chlorocyclophosphamide: synthesis, metabolism, and antitumor activity of the cis and trans isomers.
Foster AB; Jarman M; Kinas RW; van Maanen JM; Taylor GN; Gaston JL; Parkin A; Richardson AC
J Med Chem; 1981 Dec; 24(12):1399-403. PubMed ID: 7310816
[TBL] [Abstract][Full Text] [Related]
2. The metabolism and antitumour activity of the enantiomers of cis- and trans-4-methylcyclophosphamide.
Farmer PB; Jarman M; Facchinetti T; Pankiewicz K; Stec WJ
Chem Biol Interact; 1977 Jul; 18(1):47-57. PubMed ID: 890840
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitumor activity of 6-trifluoromethylcyclophosphamide and related compounds.
Farmer PB; Cox PJ
J Med Chem; 1975 Nov; 18(11):1106-10. PubMed ID: 1177256
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of 3-halocyclophosphamides and analogous compounds as novel anticancer "pro-prodrugs".
Zon G; Ludeman SM; Ozkan G; Chandrasegaran S; Hammer CF; Dickerson R; Mizuta K; Egan W
J Pharm Sci; 1983 Jun; 72(6):687-91. PubMed ID: 6875830
[TBL] [Abstract][Full Text] [Related]
5. NMR spectroscopic studies of intermediary metabolites of cyclophosphamide. A comprehensive kinetic analysis of the interconversion of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and the concomitant partitioning of aldophosphamide between irreversible fragmentation and reversible conjugation pathways.
Zon G; Ludeman SM; Brandt JA; Boyd VL; Ozkan G; Egan W; Shao KL
J Med Chem; 1984 Apr; 27(4):466-85. PubMed ID: 6708049
[TBL] [Abstract][Full Text] [Related]
6. Binding of metabolites of cyclophosphamide to DNA in a rat liver microsomal system and in vivo in mice.
Hemminki K
Cancer Res; 1985 Sep; 45(9):4237-43. PubMed ID: 4028012
[TBL] [Abstract][Full Text] [Related]
7. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
Chang TK; Waxman DJ
Cancer Res; 1993 Jun; 53(11):2490-7. PubMed ID: 8495410
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antitumor activity of cyclophosphamide analogues. 3. Preparation, molecular structure determination and anticancer screening of racemic cis- and trans-4-phenylcyclophosphamide.
Boyd VL; Zon G; Himes VL; Stalick JK; Mighell AD; Secor HV
J Med Chem; 1980 Apr; 23(4):372-5. PubMed ID: 7381836
[TBL] [Abstract][Full Text] [Related]
9. The use of deuterated analogs in qualitative and quantitative investigations of the metabolism of cyclophosphamide (NSC-26271).
Cox PJ; Farmer PB; Foster AB; Gilby ED; Jarman M
Cancer Treat Rep; 1976 Apr; 60(4):483-91. PubMed ID: 1277225
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and study of a spin-labeled cyclophosphamide analogue, 3-(1-oxy-2,2,6,6-tetramethyl-4-piperidinyl)cyclophosphamide.
Tsui FP; Robey FA; Engle TW; Ludeman SM; Zon G
J Med Chem; 1982 Sep; 25(9):1106-10. PubMed ID: 7131492
[TBL] [Abstract][Full Text] [Related]
11. Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide.
Struck RF; Dykes DJ; Corbett TH; Suling WJ; Trader MW
Br J Cancer; 1983 Jan; 47(1):15-26. PubMed ID: 6821629
[TBL] [Abstract][Full Text] [Related]
12. Effects of enantiomeric homogeneity on the in vitro metabolism and in vivo anticancer activity of (+)- and (-)-cyclophosphamide.
Tsui FP; Brandt JA; Zon G
Biochem Pharmacol; 1979; 28(3):367-74. PubMed ID: 426853
[No Abstract] [Full Text] [Related]
13. Antitumor activity of halogen analogs of phosphoramide, isophosphoramide, and triphosphoramide mustards, the cytotoxic metabolites of cyclophosphamide, ifosfamide, and trofosfamide.
Struck RF; Schmid SM; Waud WR
Cancer Chemother Pharmacol; 1994; 34(3):191-6. PubMed ID: 8004750
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antitumor properties of activated cyclophosphamide analogues.
Borch RF; Canute GW
J Med Chem; 1991 Oct; 34(10):3044-52. PubMed ID: 1920355
[TBL] [Abstract][Full Text] [Related]
15. Chemically stable, lipophilic prodrugs of phosphoramide mustard as potential anticancer agents.
Kwon CH; Moon KY; Baturay N; Shirota FN
J Med Chem; 1991 Feb; 34(2):588-92. PubMed ID: 1995881
[TBL] [Abstract][Full Text] [Related]
16. Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis.
Low JE; Borch RF; Sladek NE
Cancer Res; 1982 Mar; 42(3):830-7. PubMed ID: 7059981
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of the cis and trans isomers of N-nitroso-2,6-dimethylmorpholine and their deuterated analogs by liver microsomes of rat and hamster.
Kokkinakis D; Hollenberg PF; Scarpelli DG
Carcinogenesis; 1984 Aug; 5(8):1009-14. PubMed ID: 6744510
[TBL] [Abstract][Full Text] [Related]
18. Effects of phosphoramide mustard and acrolein, cytotoxic metabolites of cyclophosphamide, on mouse limb development in vitro.
Hales BF
Teratology; 1989 Jul; 40(1):11-20. PubMed ID: 2763206
[TBL] [Abstract][Full Text] [Related]
19. Plasma concentrations of 4-hydroxycyclophosphamide and phosphoramide mustard in patients repeatedly given high doses of cyclophosphamide in preparation for bone marrow transplantation.
Sladek NE; Doeden D; Powers JF; Krivit W
Cancer Treat Rep; 1984 Oct; 68(10):1247-54. PubMed ID: 6395951
[TBL] [Abstract][Full Text] [Related]
20. Glutathione conjugation with phosphoramide mustard and cyclophosphamide. A mechanistic study using tandem mass spectrometry.
Yuan ZM; Smith PB; Brundrett RB; Colvin M; Fenselau C
Drug Metab Dispos; 1991; 19(3):625-9. PubMed ID: 1680629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
